Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Parkinsons Dis ; 13(7): 1185-1197, 2023.
Article in English | MEDLINE | ID: mdl-37840503

ABSTRACT

BACKGROUND: Some reports suggest that psychotic features may occur in the early stages of Parkinson's disease (PD), but sensitive tools have not been utilized. OBJECTIVE: The aim was to evaluate the presence of psychotic symptoms using detailed scales and to assess the association with clinical characteristics. METHODS: Healthy controls and patients within three years of PD onset were recruited. Participants were examined for psychotic symptoms using two different instruments: the Comprehensive Assessment of At-Risk Mental States (CAARMS) and a 10 question PD specific psychosis severity scale (10PDQ). In the PD group, medication use, motor and non-motor symptoms were documented. RESULTS: Based on CAARMS and 10PDQ scales, psychotic features were present in 39% (27/70) of patients and 4% (3/74) of controls. The prevalence of passage hallucinations and illusions was significantly higher in PD compared to the control group. The presence of PD-associated psychotic features was not significantly affected by medication, motor severity or global cognitive status. Higher prevalence of overall non-motor manifestations, REM sleep behavior disorder (RBD) and depressive symptoms was significantly associated with the manifestation of psychotic features in PD [(adjusted OR:1.3; 95% CI:1.1-1.6; p = 0.003), (adjusted OR:1.3; 95% CI:1.0-1.6; p = 0.023), and (adjusted OR:1.2; 95% CI:1.0-1.4;p = 0.026)]. CONCLUSIONS: Psychotic phenomena mainly of minor nature are highly common in early PD. Cumulative non-motor symptoms, RBD and depressive features are associated with the presence of psychotic symptoms in this non-demented, early-stage PD population. More studies are needed to clarify the mechanisms that contribute to the onset of psychotic features in early PD.


Subject(s)
Parkinson Disease , Psychotic Disorders , REM Sleep Behavior Disorder , Humans , Parkinson Disease/complications , Parkinson Disease/diagnosis , Parkinson Disease/epidemiology , Psychotic Disorders/diagnosis , Psychotic Disorders/epidemiology , Psychotic Disorders/etiology , Hallucinations/diagnosis , Hallucinations/epidemiology , Hallucinations/etiology , REM Sleep Behavior Disorder/diagnosis , REM Sleep Behavior Disorder/epidemiology , REM Sleep Behavior Disorder/etiology , Prevalence
2.
J Neurol ; 270(12): 5773-5783, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37555925

ABSTRACT

OBJECTIVES: The aim was to explore the correlations between Jumping to Conclusions (JtC) tendency and neuropsychiatric features in patients with early Parkinson's disease (PD). BACKGROUND: According to few reports, PD patients with impulsive-compulsive behaviors (ICBs) are prone to working memory difficulties including JtC bias. The correlation of psychotic features and JtC tendency remains still unclear. METHODS: Healthy controls and patients within 3 years of PD onset were recruited. Participants were examined for psychotic symptoms using a 10 question PD-specific psychosis severity scale. JtC was measured by a probalistic reasoning scenario (beads task). In PD group, medication use, motor and non-motor symptoms were documented. Impulsivity was evaluated using the Questionnaire for Impulsive-Compulsive Disorders in PD (QUIP). RESULTS: The prevalence of JtC bias was 9% (6/70) in healthy individuals, compared to 32% (22/68) of PD group [p = 0.001]. No association was detected between the presence of JtC tendency and PD-associated psychosis (p = 0.216). Patients with JtC had shorter duration of PD, more tremor-dominant PD subtype and higher QUIP scores, regardless of the dopaminergic therapy (p = 0.043, p = 0.015, p = 0.007, respectively). A trend towards attention and inhibition control deficit was noticed in JtC patients. CONCLUSIONS: We found a high prevalence of JtC bias in early, cognitively intact PD population and a potential link between subthreshold ICBs and poor performance on beads task. Additional studies are needed to confirm our results and elaborate on the mechanisms that correlate impulsivity with JtC tendency, which are likely to be different from those mediating psychotic features in early PD.


Subject(s)
Parkinson Disease , Psychotic Disorders , Humans , Parkinson Disease/complications , Parkinson Disease/epidemiology , Psychotic Disorders/epidemiology , Psychotic Disorders/etiology , Psychotic Disorders/diagnosis , Impulsive Behavior/physiology , Surveys and Questionnaires , Memory, Short-Term/physiology
3.
Headache ; 50(8): 1371-7, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21044281

ABSTRACT

OBJECTIVE: To explore the efficacy and tolerability of levetiracetam in medical treatment of trigeminal neuralgia. BACKGROUND: Antiepileptic drugs (AEDs) are considered as first-line treatment for trigeminal neuralgia, although their use is often limited due to incomplete efficacy and tolerability. Newer AEDs with improved safety profile may be useful in this disorder. METHODS: Patients suffering from trigeminal neuralgia (either primary or secondary) refractory to previous treatments were recruited to be treated with levetiracetam (3-4 g/day) for 16 weeks as add-on therapy, after a 2-week baseline period. Rescue medication was allowed in both the baseline and treatment phases. The primary efficacy measure was the number of attacks per day. The patients' efficacy evaluation, the patients' global evaluation for both safety and efficacy, changes in the Hamilton Depression Scale, the Hamilton Anxiety Scale, and the Quality of Life Measure Short Form-36 were secondary parameters. RESULTS: Twenty-three patients were included in the analysis. After treatment and compared to the baseline phase, the number of daily attacks decreased by 62.4%. All secondary parameters changed significantly with the exception of the Quality of Life Measure Short Form-36 score. Seven patients withdrew from the study. Five patients (21.7%) reported side effects and 2 withdrew. CONCLUSIONS: Levetiracetam may be effective and safe in trigeminal neuralgia treatment. Confirmation in a randomized controlled study is needed.


Subject(s)
Anticonvulsants/administration & dosage , Piracetam/analogs & derivatives , Trigeminal Neuralgia/drug therapy , Adolescent , Adult , Aged , Anticonvulsants/adverse effects , Female , Humans , Levetiracetam , Male , Middle Aged , Pilot Projects , Piracetam/administration & dosage , Piracetam/adverse effects , Prospective Studies , Treatment Outcome , Young Adult
4.
Exp Brain Res ; 196(3): 319-28, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19488744

ABSTRACT

In previous studies a systematic directional error (the "motor oblique effect") was found in 2D memory pointing movements of healthy adults. In this study we extend these observations to observe that healthy children displayed the same motor oblique effect. In contrast other spatial and temporal movement parameters (mean amplitude error, square directional and amplitude error, latency and the time to maximum velocity) changed with increasing age. Memory delay increased the square directional and amplitude error independent of age. Finally failure of movement inhibition during the delay was more frequent in children compared to adults. These results favor the hypothesis that the motor oblique effect related to perceptual processing biases is constant from childhood while other movement parameters are modulated by age reflecting the continuing optimization of motor control from childhood to adulthood. The dissociation of memory and age effects suggests that motor working memory is already mature in young children.


Subject(s)
Memory/physiology , Movement/physiology , Reaction Time/physiology , Space Perception/physiology , Adult , Age Factors , Analysis of Variance , Child , Female , Humans , Male , Middle Aged , Photic Stimulation/methods , Psychomotor Performance/physiology , Time Factors , Young Adult
5.
Neurogenetics ; 6(2): 85-9, 2005 May.
Article in English | MEDLINE | ID: mdl-15776278

ABSTRACT

Twenty-one unrelated patients with a history of suspected familial Alzheimer disease (FAD) were screened for mutations in PSEN1, PSEN2, and APP, the known FAD genes encoding the presenilins (PS1 and PS2) and the amyloid precursor protein (APP). The mutation detection rate was 57%. Of the nine pathogenic mutations found in 12 cases, three were in APP, one in PSEN2, and five in PSEN1, including two novel Greek mutations (L113Q and N135S). Whereas our findings suggest the possibility of single founders for the majority of mutations, we found evidence of recurrence of the APP mutations V717L and V717I.


Subject(s)
Alzheimer Disease/genetics , Amyloid beta-Protein Precursor/genetics , Membrane Proteins/genetics , Adult , Family Health , Female , Founder Effect , Humans , Male , Middle Aged , Mutation, Missense , Pedigree , Presenilin-1 , Presenilin-2
SELECTION OF CITATIONS
SEARCH DETAIL
...